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Ox40-Ligand Has a Critical Costimulatory Role
in Dendritic Cell:T Cell Interactions
B7:CD28 pathway, the best characterized costimulatory
pathway, provides essential signals for T cell activation,
but this pathway does not account for all costimulatory
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et al., 1999). Ox40 (CD134), a TNFR family member, isSummary
expressed by activated T cells (Paterson et al., 1987;
Baum et al., 1994). Cross-linking Ox40 on T cells costim-The tumor necrosis factor family molecule Ox40-
ulates proliferation and cytokine production in vitroligand (Ox40L) has been identified as a potential
(Baum et al., 1994; Godfrey et al., 1994; Flynn et al., 1998;costimulatory molecule and also has been implicated
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al., 1998). In some experimental systems, a Th2 biasthe essential functions of Ox40L, we generated and
for this pathway has been suggested (Flynn et al.,characterized Ox40L-deficient mice. Mice lacking
1998; Ohshima et al., 1998), but this bias was not foundOx40L exhibit an impaired contact hypersensitivity re-
in a T cell receptor transgenic system or in a modelsponse, a dendritic cell±dependent T cell±mediated
of experimental autoimmune encephalomyelitis (EAE)response, due to defects in T cell priming and cytokine
(Gramaglia et al., 1998; Kaleeba et al., 1998). Blockingproduction. In contrast, Ox40L-deficient mice do not
Ox40:Ox40L interactions ameliorated autoimmunity inhave defects in T cell homing or humoral immune re-
both EAE and inflammatory bowel disease modelssponses. In vitro, Ox40L-deficient dendritic cells are
(Weinberg et al., 1996, 1999; Higgins et al., 1999). Thisdefective in costimulating T cell cytokine production.
pathway also has been reported to be essential for BThus, Ox40L has a critical costimulatory function in
cell activation and humoral immunity (Stuber et al., 1995;vitro and in vivo for dendritic cell:T cell interactions.
Stuber and Strober, 1996), and a role in T cell homing
to activated endothelium has been suggested as wellIntroduction
(Imura et al., 1996, 1997). Finally, cross-linking Ox40L in
vitro with anti-Ox40L antibodies enhanced human den-Costimulation has become an area of intense investiga-
dritic cell activation and maturation, implying a role fortion because a mechanistic understanding of costimula-
Ox40:Ox40L in dendritic cell:T cell interactions (Ohshimatory signals may enable rational therapeutic approaches
et al., 1997).for manipulating immune responses. According to the
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mouse. Our results provide evidence that OX40L has a1999). In the absence of a costimulatory signal, T cell
key role in the costimulatory function of dendritic cells.receptor engagement not only can result in a failure
Mice lacking OX40L exhibit an impaired contact hyper-to induce an immune response but also can lead to
sensitivity response, an in vivo dendritic cell±dependentfunctional T cell inactivation, resulting in tolerance. The
model of T cell±mediated immunity, due to defects in T
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Figure 1. Generation of Ox40L-Deficient Mice
(A) Design of the Ox40L targeting construct (top). The neomycin resistance gene (neo) is flanked by 59 10 kb and 39 2 kb genomic DNA
fragments. The thymidine kinase gene (TK) is external to the 59 genomic fragment. The BamHI (B), XbaI (X), and HindIII (H) sites shown were
used to generate the construct. Organization of the wild-type Ox40L targeted region (middle). The extracellular domain of Ox40L (shaded
box) and 39 untranslated region (hatched box) are encoded by a single exon. The genomic probe for Southern blotting is the HindIII±NcoI (N)
fragment that lies external to the 39 genomic fragment used in the targeting construct (slashed box). Structure of the predicted targeted allele
(bottom). The homologous recombination event results in the replacement of the entire extracellular domain contained in the 4.5 kb BamHI±XbaI
genomic fragment with the neomycin cassette. Southern blot analysis uses the introduction of a neomycin cassette SpeI (S) site and the
deletion of an endogenous SpeI site. Orientation of transcription frame is indicated by arrows.
(B) Southern blot analysis of tail DNA from wild-type (1/1), Ox40L heterozygous (1/2), and knockout (2/2) littermates showing the endogenous
(10 kb) and targeted (5.5 kb) bands.
(C) Staining of 3T3 wild-type and Ox40L transfectant cell lines demonstrating that FITC-conjugated 11f5 antibody (solid line) specifically
recognizes Ox40L relative to isotype control (dashed line). Cells were stained in parallel with Ox40-Ig (solid line) or control fusion protein
(dashed line).
(D) Wild-type, but not Ox40L-deficient, activated dendritic cells express Ox40L. Dendritic cells were purified from wild-type and Ox40L2/2
splenocytes and stimulated with 10 mg/ml anti-CD40 for 2 days. Cells were stained for Ox40L expression with Ox40-Ig fusion protein or anti-
Ox40L 11f5 antibody (solid lines) and with isotype matched controls (dashed lines).
Results maturation of thymocytes in wild-type and Ox40L2/2
mice. Likewise, analyses of spleen and lymph nodes
from wild-type and Ox40L2/2 mice revealed comparableGeneration of Ox40L-Deficient Mice
We generated mice lacking Ox40L expression numbers of B cells, T cells, and T cell subsets, and
expression of the activation markers CD25 and CD69(Ox40L2/2) by replacing the entire extracellular domain
and part of the 39 untranslated region of Ox40L, a Type also were similar. No significant differences were found
by histology between naive wild-type and Ox40L2/2II transmembrane protein, with the neomycin drug resis-
tance gene (Figure 1A). This targeted mutation elimi- mice in spleen, thymus, lymph node, bone marrow, or
any other major organs examined (data not shown).nates Ox40L binding to Ox40. Germline transmitting chi-
meric mice generated from targeted ES cells were bred
to 129/Sv mice, and progeny heterozygous for the
Ox40L mutation were interbred to generate Ox40L-defi- Characterization of Ox40L Expression
To confirm the absence of Ox40L protein expression,cient mice (Figure 1B). Ox40L2/2 mice were viable, and
the genotypes of progeny resulting from heterozygous we generated antibodies against murine Ox40L by im-
munizing Ox40L2/2 mice with 3T3 transfectant lines sta-intercrosses followed normal Mendelian ratios. Flow cy-
tometric analyses revealed comparable numbers and bly expressing high levels of Ox40L. Anti-Ox40L titers
Ox40L Is Critical for Dendritic Cell Function
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Figure 2. Contact Hypersensitivity Responses
For oxazolone-induced CHS, wild-type (WT)
and Ox40L2/2 (KO) mice were sensitized with
0.05% oxazolone (A) or 1.0% oxazolone (B)
and then challenged with 1% oxazolone on
the ear 5 days later. For DNFB-induced CHS,
mice were sensitized with 0.1% DNFB on
days 4 and 5 prior to challenge with 0.25%
DNFB on the ear (C). For FITC-induced CHS,
mice were sensitized with 0.5% FITC and
then challenged on the ear 5 days later with
0.5% FITC (D). Ear swelling shown was at
the time of maximal response after challenge,
which was day 2 for (A) and (B) and day 1 for
(C) and (D). Control groups (NS) were chal-
lenged only and not sensitized. Data shown
are mean 6 standard error of each group
(nine mice per group for [A]; four for [B]; eight
for [C]; and five for [D]).
were determined by ELISA using Ox40L-Ig fusion pro- cells; (2) the Ox40:Ox40L pathway has been implicated
in dendritic cell:T cell activation; (3) epidermal dendritictein. Hybridoma clones were screened first for binding
to Ox40L-Ig by ELISA and then for binding to Ox40L (Langerhans) cells are the sole APC population essential
for CHS sensitization (Streilein et al., 1980; Toews et al.,transfectant cells by FACS. Clones with high specific
reactivity were subcloned and screened twice. The 11f5 1980); and (4) Ox40L has been linked to T cell homing,
which is a necessary step in the CHS response.clone, a murine IgG1 k antibody, was used for expres-
sion studies, because it had the highest specific mean Ox40L2/2 mice exhibited significantly decreased ear
swelling (,60% of wild-type) when sensitized with oxa-fluorescence by FACS (data not shown). The 11f5 mono-
clonal antibody (mAb) and Ox40-Ig bound to 3T3-Ox40L zolone at either low (0.05%; p , 0.0001) or high (1.0%;
p , 0.05) doses of oxazolone (Figures 2A and 2B). Thisand 300.19-Ox40L transfectant cells but did not bind to
parental 3T3 or 300.19 cells (Figure 1C; data not shown). significant decrease in CHS responses was also ob-
served when either the Th1 predominant allergen dini-Because Ox40L expression had been detected on
anti-CD40 activated human dendritic cells, we examined tro-fluorobenzene (DNFB) (,35% of wild-type; p ,
0.0001) or the Th2 predominant allergen FITC (,40% ofactivated murine dendritic cells for expression of Ox40L.
Dendritic cells are APCs key to initiating and modulating wild-type; p , 0.003) was used as the allergen (Figures
2C and 2D) (Thomson et al., 1993; Simon et al., 1994;an immune response (reviewed in Banchereau and
Steinman, 1998; Cella et al., 1997). Dendritic cells were Tang et al., 1996).
Since Ox40:Ox40L interactions have been implicatedisolated from Flt3-ligand (Flt3L)-treated mice, activated
in vitro with anti-CD40 for 2 days, and then stained for in T cell homing to sites of inflammation as well as den-
dritic cell:T cell activation, we next examined whetherOx40L expression with Ox40-Ig and anti-Ox40L 11f5
mAb. Activated Ox40L wild-type, but not deficient, den- the defect seen in CHS occurred in the sensitization or
challenge phases of the CHS response. A dendritic celldritic cells expressed Ox40L (Figure 1D). Cells were acti-
vated as demonstrated by upregulation of B7-1 and defect would presumably take place in the sensitization
phase, whereas a homing defect would occur in theB7-2 expression (data not shown). Unactivated dendritic
cells did not express Ox40L (data not shown). Identical challenge phase. Importantly, epidermal dendritic cells
are not essential for the challenge phase (Grabbe et al.,Ox40L expression results were obtained by using acti-
vated dendritic cells isolated initially from naive, non- 1995). To examine this issue, wild-type and Ox40L2/2
mice were sensitized with oxazolone, and sensitizedFlt3L-treated mice and by using two different Ox40-Ig
fusion proteins (data not shown). Similar lack of Ox40L draining lymph node cells were adoptively transferred
into naive wild-type and Ox40L2/2 recipients (Figureexpression was noted on activated Ox40L2/2 T cells
and B cells (data not shown). Wild-type dendritic cells 3A). When challenged with oxazolone, wild-type and
Ox40L2/2 recipients of wild-type cells exhibited similarexpressed higher levels of Ox40L than B and T cells, as
assayed by FACS (data not shown). The lack of Ox40- ear swelling responses after challenge (p . 0.8). In con-
trast, wild-type mice adoptively transferred with sensi-Ig binding to Ox40L-deficient cells suggests that there
is not an alternative Ox40 counter receptor. tized Ox40L2/2 lymph node cells had significantly de-
creased CHS responses relative to wild-type recipient
mice adoptively transferred with sensitized wild-typeContact Hypersensitivity Responses
in Ox40L2/2 Mice cells (,20% of wild-type; p , 0.008). Consistent with
these findings, Ox40L2/2 mice were not defective in phe-We examined contact hypersensitivity (CHS) (reviewed
in Grabbe and Schwarz, 1998) in the Ox40L2/2 strain nol- or croton oil±induced irritant dermatitis (data not
shown), a model analogous to the final challenge phasebecause (1) Ox40L is expressed on wild-type dendritic
Immunity
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Figure 3. The Ox40L2/2 CHS Defect Is in the
Sensitization Phase
(A) Adoptive transfer CHS responses. Wild-
type (WT) and Ox40L2/2 (KO) mice were sen-
sitized with 0.05% oxazolone. Five days later,
draining lymph node cells were harvested,
and 25 3 106 cells were adoptively transferred
into wild-type or Ox40L2/2 recipient mice.
Mice were then immediately challenged on
the ear with 1.0% oxazolone, and ear swelling
was measured 2 days later. Control group
(none) did not receive transferred cells. Data
shown are mean 6 standard error of each
group (four mice per recipient group).
(B) Ox40L2/2 dendritic cells can acquire anti-
gen and migrate to draining lymph nodes.
Wild-type and Ox40L2/2 mice were epicuta-
neously sensitized with 0.5% FITC. Wild-type
control mice (NS) were not sensitized. One
day later, draining lymph nodes were har-
vested, and enriched dendritic cells were ex-
amined for FITC expression by FACS. Data
shown are FITC expression on CD11c1 gated
cells and percentage of cells within indicated
marker. Wild-type and Ox40L2/2 mice did not
differ significantly in FITC expression.
steps in CHS. These results demonstrate that the CHS of wild-type) interferon-g (IFNg) than wild-type lymph
node cells. Since the primary effectors of CHS aredefect in the Ox40L2/2 mouse occurs in the sensitization
phase and not in the challenge phase, in particular not thought to be CD81 T cells, whereas CD41 T cells may
act as either effector or regulatory cells (Gocinski andduring the homing of T cells to the challenge site.
A sensitization phase CHS defect might be due to a Tigelaar, 1990; Bour et al., 1995; Cavani and Katz, 1995,
J. Investig. Dermatol., abstract; Kondo et al., 1996; Xu etfailure in antigen acquisition or migration by dendritic
cells. To address these possibilities, we isolated den- al., 1996), we examined whether there was a difference in
the priming of CD41 and CD81 T cell subsets. Thy1.21dritic cells from draining lymph nodes after epicuta-
neous sensitization with FITC. Comparable numbers of T cells, CD41 T cells, and CD81 T cells were isolated
from the draining lymph nodes of oxazolone-sensitizedFITC positive CD11c1 dendritic cells were obtained from
the draining lymph nodes of wild-type and Ox40L2/2 mice and restimulated in vitro with oxazolone-conju-
gated wild-type whole spleen cells (Figure 4C). Ox40L2/2mice 1 day after sensitization with FITC (Figure 3B),
indicating that the CHS defect was not due to a failure in Thy1.21, CD41, and CD81 T cells all proliferated less than
comparable wild-type cells, indicating that the primingdendritic cell antigen acquisition or migration. All FITC1
cells were I-Ab high and CD11c1 (data not shown). Total defect was not confined to either CD41 or CD81 T cells.
dendritic cell numbers were comparable in lymph node
and spleen of naive wild-type and Ox40L2/2 mice, as Costimulatory Function of Ox40L2/2 Dendritic Cells
Since there was a defect in T cell priming in vivo, wewell as in sensitized wild-type and Ox40L2/2 lymph node
and spleen (data not shown). Thus, adequate numbers evaluated the costimulatory function of Ox40L2/2 den-
dritic cells in vitro. When 129/Sv wild-type and Ox40L2/2of Ox40L2/2 dendritic cells were able to acquire antigen
and migrate to draining lymph nodes. dendritic cells were used as stimulators in a mixed lym-
phocyte reaction (MLR) with wild-type BALB/c CD41 TWe then determined whether Ox40L2/2 mice had a
defect in T cell priming in response to CHS allergens, the cell responders, wild-type and Ox40L2/2 dendritic cells
induced comparable levels of CD41 T cell proliferationnext step in CHS after dendritic cell migration. Draining
lymph node cells of wild-type and Ox40L2/2 DNFB-sen- as assessed daily over 4 days (Figure 5A; data not
shown). Strikingly, Ox40L2/2 dendritic cells stimulatedsitized mice were isolated and assayed for proliferative
responses and cytokine production upon restimulation significantly lower levels of IL-4 (,30% of wild-type)
and IFNg (,5% of wild-type) production, while IL-2 wasin vitro with dinitro-benzene-sulfonic acid (DNBS), the
water soluble analog of DNFB (Figures 4A and 4B). moderately affected (,65% of wild-type) (Figure 5B).
Similar results were obtained when BALB/c wild-typeOx40L2/2 lymph node cells proliferated markedly less
(50% of wild-type) and produced significantly less (10% and BALB/c (F8) Ox40L2/2 dendritic cells were used to
Ox40L Is Critical for Dendritic Cell Function
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Figure 4. In Vitro Restimulation of CHS Allergen-Sensitized Lymph Node Cells
(A and B) Restimulation of whole lymph node cells. Wild-type and Ox40L2/2 mice were sensitized 4 and 5 days prior to harvest with 0.1%
DNFB. Draining lymph node cells were harvested, pooled from like mice, and restimulated in vitro with DNBS.
(A) Proliferation was measured on day 3. Control mice were not sensitized. Wild-type (closed squares), Ox40L2/2 (open squares), or wild-type
control (closed diamonds). Data shown are mean 6 standard error of triplicate wells (three mice per group).
(B) Cytokine production from 100 mg/ml DNBS proliferation wells from (A) was measured by ELISA. Wild-type (filled bars), Ox40L2/2 (open
bars), or wild-type control (striped bars). Data shown are mean 6 standard error of triplicate wells. Cytokine production at lower concentrations
of DNBS was minimal, and no production was observed without DNBS (data not shown).
(C) Restimulation of T cell subsets. Wild-type and Ox40L2/2 mice were sensitized with 0.05% oxazolone. Five days later, peripheral lymph
node cells from like mice were harvested and pooled, and Thy1.21, CD41, or CD81 T cells were isolated by magnetic bead positive selection.
T cell subsets were restimulated in vitro with irradiated oxazolone conjugated wild-type stimulator splenocytes, and subsequent proliferation
was measured on day 3. Control mice were not sensitized. Wild-type (closed squares), Ox40L2/2 (open squares), or wild-type control (closed
diamonds). Data shown are mean 6 standard error of triplicate wells (three mice per group).
stimulate 129/Sv CD41 wild-type T cells (data not Similarly, wild-type and Ox40L2/2 mice generated com-
parable responses when sensitized with oxazolone-con-shown). In these MLRs, Ox40L2/2 dendritic cells ex-
pressed MHC class II, B7-1, and B7-2 at levels compara- jugated bovine serum albumin (BSA) in CFA and chal-
lenged epicutaneously with oxazolone (data not shown).ble to wild-type cells (data not shown). When Ox40L2/2
T cells were utilized as responders in MLRs, Ox40L2/2 Because DTH is primarily mediated by CD41 T cells,
while CD81 T cells are the major effectors of CHS, theT cells behaved similarly to wild-type T cells (data not
shown). difference in CHS and DTH responses in the Ox40L-
deficient strain could have been due to defects in CD81
T cell function, as well as in dendritic cell function. There-Delayed Type Hypersensitivity and CTL Responses
In contrast to CHS, classical DTH responses are medi- fore, CD81 cytotoxic T lymphocyte (CTL) function was
examined in vitro and in vivo in the Ox40L2/2 strain inated by Th1 type CD41 T cells (Cher and Mosmann,
1987; Bour et al., 1995), and epidermal dendritic cells a vesicular stomatitis virus (VSV) model (Lefkovits, 1997).
Wild-type and Ox40L2/2 mice produced comparableare not essential for DTH (Grabbe et al., 1995). To assess
whether CD41 T cell function was impaired in a response CTL responses to VSV in vivo after infection (Figure 6B).
Likewise, wild-type and Ox40L2/2 spleen cells gener-not requiring dendritic cells in vivo, we examined DTH
responses in Ox40L2/2 mice (Titus and Chiller, 1981). ated equivalent CTL responses against allo-antigen in
vitro (data not shown). Hence, CD81 CTL responses areUnlike the decreases seen in CHS, Ox40L2/2 mice dem-
onstrated responses equivalent to wild-type mice in not globally defective in the absence of Ox40L.
assays of DTH reactions. Wild-type and Ox40L2/2 mice
sensitized subcutaneously with ovalbumin (OVA) in Humoral Immune Responses of Ox40L2/2 Mice
Because an essential role for the Ox40:Ox40L path-complete Freund's adjuvant (CFA) had similar footpad
swelling responses after OVA challenge (Figure 6A; p . way in antibody responses had been suggested, the
Ox40L2/2 strain was extensively examined for defects in0.8). In addition, no differences were found when mice
were sensitized with OVA in incomplete Freund's adju- humoral immune responses. In naive mice, basal serum
immunoglobulin levels (total Ig, IgM, IgG1, and IgG2a)vant (IFA) and challenged with OVA (data not shown).
Immunity
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Figure 5. Ox40L2/2 Dendritic Cell±Induced
MLR
CD11c1 dendritic cells purified from Flt3-
ligand-treated 129/Sv (H-2b) wild-type and
Ox40L2/2 mice were irradiated and incubated
with CD41 T cells from BALB/c (H-2d) wild-
type mice. Subsequent proliferation (A) was
measured on day 4. Wild-type (closed
squares) or Ox40L2/2 (open squares). Cyto-
kine production (B) from proliferation wells
was measured by ELISA on day 3 for IL-2 and
day 4 for IL-4 and IFNg. Wild-type (filled bars)
or Ox40L2/2 (open bars). CD41 T cells without
dendritic cells did not produce cytokines, and
dendritic cells alone did not produce cytokines
(data not shown). Data shown are mean 6
standard error of triplicate wells.
were identical between wild-type and Ox40L2/2 mice mice produced anti-TNP±specific isotypes comparable
to wild-type mice (Figure 7A; data not shown). Ox40L2/2(data not shown). To compare antigen-specific T±depend-
ent antibody responses in wild-type and Ox40L2/2 mice also were immunized in the absence of adjuvant,
since adjuvants can upregulate the expression of othermice, mice were immunized with the hapten-protein
conjugates, 2,4,6-trinitrophenyl-keyhole limpet hemo- costimulatory pathways that could potentially compen-
sate for Ox40L. Wild-type and Ox40L2/2 mice immunizedcyanin (TNP-KLH) or TNP-ovalbumin (TNP-OVA), and
the induction of TNP-specific serum antibody isotypes with TNP-KLH in PBS intravenously (IV) generated
equivalent anti-TNP antibody responses as well (datain vivo was examined (Stuber and Strober, 1996; Bor-
riello et al., 1997). Because Ox40 and Ox40L are upregu- not shown). Of note, wild-type and Ox40L2/2 mice made
equivalent anti-VSV antibody responses after VSV infec-lated by inflammatory stimuli, we immunized Ox40L2/2
mice in the presence of adjuvants. When immunized tion (data not shown). To further analyze humoral re-
sponses, spleens and lymph nodes were harvested fromwith TNP-KLH in CFA by the intraperitoneal route (IP),
TNP-KLH in CFA subcutaneously (SC), TNP-KLH in IFA/ wild-type and Ox40L2/2 mice 1 week post immunization
with TNP-KLH in CFA/SC or TNP-KLH in IFA/SC andIP, TNP-KLH in IFA/SC, or TNP-OVA in CFA/IP, Ox40L2/2
Figure 6. DTH and CTL Responses
(A) Delayed type hypersensitivity. Wild-type
(WT) or Ox40L2/2 (KO) mice were immunized
subcutaneously with OVA in CFA. Seven days
later, mice were challenged in the footpad
with heat-aggregated OVA, and footpad
swelling was measured 2 days after chal-
lenge. Wild-type control mice (NS) were not
sensitized. Data shown are mean 6 standard
error of each group (five mice per group).
(B) VSV-specific MHC class I restricted CTL
responses. VSV-specific CTL effectors were
generated by infection of wild-type and
Ox40L2/2 mice with VSV. After 6 days, spleno-
cytes were harvested and incubated with
51Cr-labeled EL4 target cells pulsed with VSV peptide, and specific lysis was measured. Control mice were not immunized with VSV. EL4 cells
without peptide were not lysed at any effector/target ratio (data not shown). Wild-type VSV immunized (closed squares) or control (closed
circles). Ox40L2/2 VSV immunized (open squares) or control (open circles). Data shown are means of triplicate wells from each group, and
standard errors were less than 5% (two mice per group).
Ox40L Is Critical for Dendritic Cell Function
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Figure 7. Antibody Responses
(A) Primary antibody responses. Wild-type and Ox40L2/2 mice were immunized with TNP-KLH in CFA/IP. After 7 days, mice were bled, and
sera were analyzed for anti-TNP-specific antibodies (IgM, IgG1, and IgG2A) by ELISA. Wild-type (closed squares), Ox40L2/2 (open squares),
or preimmune (closed diamonds). Data shown are mean 6 standard error of each group (five mice per group).
(B) Recall antibody responses. Wild-type and Ox40L2/2 mice were immunized with TNP-KLH in CFA/IP and boosted with TNP-KLH in IFA/IP
8 weeks later. After 6 days, mice were bled, and sera were analyzed for anti-TNP-specific antibodies (IgM, IgG1, and IgG2A) by ELISA. Wild-
type (closed squares), Ox40L2/2 (open squares), or preimmune (closed diamonds). Data shown are mean 6 standard error of each group (four
mice per group).
examined histologically. Immunohistochemical analy- lymph nodes during the sensitization phase of the re-
sponse. Both T cell proliferation and cytokine produc-ses of spleens and lymph nodes from wild-type and
Ox40L2/2 mice revealed comparable germinal center tion were reduced in Ox40L2/2 mice. As demonstrated
by the adoptive transfer experiments, the homing of Tformation and similar architecture of B cell and CD41 T
cell zones (data not shown). In addition, recall antibody cells to sites of inflammation was not defective. In vitro,
Ox40L2/2 dendritic cells exhibited defects in costimulat-responses of Ox40L2/2 mice also were comparable to
wild-type, when mice previously immunized with TNP- ing both IFNg and IL-4 production by CD41 T cells. Our
studies do not support a differential role for Ox40L inKLH in CFA/IP or TNP-KLH in PBS/IV were boosted 2
months later with TNP-KLH in IFA/IP or TNP-KLH in Th1 versus Th2 differentiation, since both IFNg and IL-4
production were affected, and both DNFB and FITC-PBS/IV, respectively (Figure 7B; data not shown). T-inde-
pendent (IgM), Th1 type (IgG2A), and Th2 type (IgG1) induced CHS were inhibited. However, our results do
not preclude a role for Ox40L in sustaining an immuneanti-TNP antibody isotypes were all equivalent between
wild-type and Ox40L2/2 mice in every immunization con- response, as has been suggested (Gramaglia et al.,
1998; Weinberg et al., 1999).dition examined.
The absence of defects in humoral immunity and DTH
in the Ox40L2/2 strain is in marked contrast to the CHSDiscussion
defect. This difference may most likely be due to the
primary role of epidermal dendritic cells as APCs in theRecent work has implicated the Ox40:Ox40L pathway
in T cell homing, humoral immunity, dendritic cell func- priming of CHS responses, whereas other APC types
can substitute for dendritic cells in other T cell re-tion, and T cell activation and differentiation. To define
the essential functions of this pathway, we generated sponses. Alternatively, humoral and DTH responses may
be dependent upon dendritic cells, but the Ox40:Ox40Land analyzed Ox40L-deficient mice. The phenotype of
Ox40L2/2 mice demonstrates a critical costimulatory pathway may be dispensable for dendritic cell costimu-
latory function in these responses. The intact humoralrole for Ox40L on dendritic cells. Contact hypersensitiv-
ity, a dendritic cell±dependent T cell±mediated re- immune responses observed in the Ox40L2/2 mouse are
contrary to studies using anti-Ox40 polyclonal antibod-sponse, was impaired in Ox40L2/2 mice. By dissecting
steps in the CHS pathway, we found that the defect was ies (Stuber et al., 1995; Stuber and Strober, 1996). In
fact, the anti-Ox40L antibodies were generated in thein the priming of allergen-specific T cells in draining
Immunity
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from a 129/Sv-derived genomic library. The targeting vector wasOx40L-deficient mouse. The most likely explanation for
generated as described in Figure 1A, introduced into J1 embryonicthe prior reports could be antibody-mediated deletion
stem (ES) cells, and G418- and FIAU-resistant colonies were ex-of Ox401 activated T cells, although it is formally possi-
panded. DNA was prepared and analyzed by Southern blotting using
ble that compensatory pathways may have developed a 39 external probe (NcoI±HindIII), as in Figure 1. Single integrants
in the Ox40L2/2 mouse. were identified by Southern blot using a neomycin probe. Four dis-
Other costimulatory interactions, particularly the B7: tinct ES cell lines heterozygous for Ox40L were microinjected into
C57BL/6 and BALB/c blastocysts and gave rise to germline trans-CD28, CD40:CD154, and RANK:RANKL pathways, also
mission. Identical experimental results were obtained with mice de-have an important role in dendritic cell:T cell interac-
rived from all four clones. Chimeric mice were bred with 129/Sv micetions. Although mice lacking both B7-1 and B7-2 have
to produce inbred 129/Sv Ox40L1/2 mice that were intercrossed to
impaired CHS ear swelling responses at low allergen generate Ox40L-deficient mice. Ox40L2/2 BALB/c mice were ob-
dose, they have responses comparable to wild-type at tained by backcrossing for eight generations. Mice were genotyped
high allergen dose (Rauschmayr-Kopp et al., 1998). In by Southern blot.
contrast, Ox40L2/2 mice have impaired CHS responses
Generation of Anti-Ox40L Antibodiesat both low and high allergen doses. CTLA4-Ig treatment
The Ox40L cDNA was introduced into pLEN (Gimmi et al., 1991)of wild-type mice, which blocks B7 interactions, inhib-
and transfected into wild-type 3T3 cells with a selectable neomycinited CHS responses to the Th1 predominant allergen
resistance plasmid. 3T3 transfectants were selected using G418,DNFB but not to the Th2 prone allergen FITC (Tang
sorted by FACS using Ox40-Ig, and cloned. The Ox40-Ig fusion
et al., 1996). Likewise, CD40:CD154 blockade inhibited proteins have been described (Calderhead et al., 1993; Baum et al.,
CHS responses to DNFB but was insufficient to block 1994). Ox40L-deficient mice were immunized with 5 3 106 3T3-
CHS responses to FITC (Tang et al., 1996). Simultaneous Ox40L transfectant cells in CFA SC followed by boosts at 2 and 5
weeks. Sera were titered for anti-Ox40L reactivity by ELISA againstblockade of both the B7:CD28 and CD40:CD154 path-
Ox40L-Ig, as described with anti-TNP ELISA (Borriello et al., 1997),ways was necessary to inhibit CHS responses to FITC
except that plates were coated with Ox40L-Ig. Splenocyte fusionin wild-type mice (Tang et al., 1996). Strikingly, Ox40L2/2
was performed (Kohler and Milstein, 1975), and clones with specific
mice have defective responses to both allergens. Unlike reactivity against Ox40L-Ig by ELISA and Ox40L transfectants by
the Ox40:Ox40L pathway, the B7:CD28, CD40:CD40L, FACS were subcloned and screened twice. Antibody isotyping was
and RANK:RANKL interactions have essential roles in performed using the Mouse Immunoglobulin IsoStrip kit (Boehringer
Mannheim). 11f5 ascites were produced, and antibody was purifiedresponses not demonstrated to be critically dependent
using Protein A/G (Pierce) and conjugated to FITC (Colligan et al.,upon dendritic cell costimulatory function. The B7:CD28
1994).and CD40:CD40L pathways are both essential for hu-
moral immunity (Borriello et al., 1997; Vogel and Noelle,
Cell Preparations and Cultures1998), and RANKL has an obligatory role in lymph node
Leukocyte populations were isolated using the microbeads and LS
organogenesis, T cell development, and bone marrow columns on a MACS setup (Miltenyi Biotec). For T cells, the beads
formation (Kong et al., 1999). Thus, our studies suggest used were CD4, CD8, and Thy1.2. For dendritic cells, Flt3-ligand-
that the Ox40L pathway may be more important for treated mice were used to generate large numbers of cells (Mara-
skovsky et al., 1996), followed by CD11c1 microbead purificationdendritic cell function under some conditions than the
or by low-density centrifugation and overnight plastic adherencewell-characterized B7:CD28 and CD40:CD154 pathways.
(Colligan et al., 1994). Dendritic cells also were obtained from naiveOur results have therapeutic implications and suggest
mice by centrifugation and adherence (Colligan et al., 1994). Similar
that manipulation of the Ox40:Ox40L pathway would expression and MLR cytokine and proliferation results were ob-
be most beneficial during the induction of an immune tained using dendritic cells isolated by all three methods. Purity of
response involving dendritic cells, such as DNA vaccina- cells isolated by the MACS system was 95% and, for centrifugation
and adherence, 75%.tion, diabetes, or graft versus host disease. In fact, pre-
liminary studies indicate that Ox40L-deficient recipient
Cell Surface Stainingmice can have a significant survival advantage over wild-
Flow cytometry was performed as described (Baum et al., 1994;type recipients when adoptively transferred with alloge-
Colligan et al., 1994). Monoclonal antibodies were obtained fromneic wild-type T cells in a model of acute lethal graft
PharMingen. Polyclonal F(ab9)2 antibodies were goat anti-speciesversus host disease (B. Blazar et al., unpublished data). isotype-specific depleted for cross-reactivity and obtained from
Further investigation of the Ox40:Ox40L pathway should Jackson Immunoresearch. Dendritic cells were plated at 1.5 3 106/
contribute to our fundamental understanding of costim- ml and stimulated with 10 mg/ml soluble anti-CD40 (clone 3/23 [Has-
bold et al., 1994]).ulation and dendritic cell function and also provide new
avenues for clinical intervention.
Contact Hypersensitivity
Oxazolone-induced CHS was assayed as described (Rauschmayr-Experimental Procedures
Kopp et al., 1998). For DNFB, mice were sensitized epicutaneously
with 0.1% DNFB dissolved in acetone:olive oil (4:1) on days 0 andMice
1 and then challenged epicutaneously on day 5 with 0.25% DNFB.All experiments used 129/Sv inbred animals unless otherwise noted.
For FITC, mice were sensitized epicutaneously with 0.5% FITC dis-129/Sv mice were obtained from our own breeding colony or from
solved in acetone:dibutyl-pthalate (1:1) and then challenged epicu-Jackson Laboratory (JR2448). Wild-type BALB/c mice were ob-
taneously 5 days later with 0.5% FITC. Data shown are from timetained from Taconic Farms. Mice were maintained in a specific
point of maximal swelling. For adoptive transfer response, micepathogen-free, virus antibody±free facility administered by Harvard
were sensitized with 0.05% oxazolone. On day 5, draining lymphMedical School in accordance with the institutional guidelines of
nodes were harvested, pooled from like mice, and single cell suspen-Harvard Medical School and Brigham and Women's Hospital, which
sions were prepared. Cells were washed in PBS, and 25 3 106are AAALAC accredited institutions.
cells were adoptively transferred into recipient mice. Mice were
immediately challenged with oxazolone as above. For FITC-inducedGeneration of Ox40L-Deficient Mice and Genotyping
dendritic cell migration, mice were epicutaneously sensitized withTwo l clones encoding the extracellular domain and 39 untranslated
region of Ox40L and adjacent noncoding sequences were isolated FITC as above and then analyzed as described (Catalina et al., 1996).
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Statistics were calculated using the parametric paired t test set to Cella, M., Sallusto, F., and Lanzavecchia, A. (1997). Origin, matura-
tion and antigen presenting function of dendritic cells. Curr. Opin.95% confidence interval and 2-sided p value.
Immunol. 9, 10±16.For whole lymph node restimulation, mice were sensitized with
DNFB. Draining lymph node cells (inguinal and axillary) were har- Cher, D.J., and Mosmann, T.R. (1987). Two types of murine helper
vested 5 days after initial sensitization and pooled from like mice. T cell clone. II. Delayed-type hypersensitivity is mediated by TH1
Cells at 1 3 106/ml were restimulated with DNBS in triplicate wells clones. J. Immunol. 138, 3688±3694.
as in Figure 4. Cytokine data are from maximal time point of assay Colligan, J., Kruisbeck, A., Marguiles, D., Shevach, E., and Strober,
and taken from proliferation wells. Proliferation and cytokines were W. (1994). Current Protocols in Immunology, R. Coico, ed. (NY: John
analyzed as described (Schweitzer and Sharpe, 1998). Wiley and Sons).
For CD41, CD81, and Thy1.21 T cell restimulation, mice were
Flynn, S., Toellner, K.M., Raykundalia, C., Goodall, M., and Lane,sensitized with oxazolone. Draining lymph nodes (inguinal and axil-
P. (1998). CD4 T cell cytokine differentiation: the B cell activationlary) were harvested on day 5 after initial sensitization, pooled from
molecule, OX40 ligand, instructs CD4 T cells to express interleukinlike mice, and T cell subsets were isolated by MACS. Irradiated,
4 and upregulates expression of the chemokine receptor, Blr-1. J.
oxazolone-conjugated wild-type splenocytes (7.5 3 104) were plated
Exp. Med. 188, 297±304.
with purified T cells in triplicate as in Figure 4. Oxazolone-conjugated
Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman,splenocytes were prepared by incubating red blood cell depleted
A.S., Morimoto, C., and Nadler, L.M. (1991). B-cell surface antigensplenocytes in 0.0375% oxazolone in 7.5% ethanol in PBS for 15 min
B7 provides a costimulatory signal that induces T cells to proliferateat 238C. Cells were irradiated, passed over Ficoll, and extensively
and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575±6579.washed. Data shown are from the maximal time point.
Gocinski, B.L., and Tigelaar, R.E. (1990). Roles of CD41 and CD81
T cells in murine contact sensitivity revealed by in vivo monoclonal
Dendritic Cell±Induced MLR antibody depletion. J. Immunol. 144, 4121±4128.
Dendritic cells from Flt3L-treated 129/Sv animals were isolated from
Godfrey, W.R., Fagnoni, F.F., Harara, M.A., Buck, D., and Engleman,
spleen by MACS. Dendritic cells (105) were irradiated and plated in
E.G. (1994). Identification of a human OX-40 ligand, a costimulator
triplicate with BALB/c CD41 T cells isolated by MACS as in Figure
of CD41 T cells with homology to tumor necrosis factor. J. Exp.
5. Proliferation and cytokine data are from time point of maximal Med. 180, 757±762.
response for each assay.
Grabbe, S., and Schwarz, T. (1998). Immunoregulatory mechanisms
involved in elicitation of allergic contact hypersensitivity. Immunol.
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